Professor Ohnuma summarises the findings of this important project Although there are a range of successful treatments available for retinoblastoma, unfortunately many of these can cause some degree of vision loss for the child. In order to be able to develop new...
A new type of in-pregnancy testing called Non-Invasive Prenatal Diagnosis (NIPD) is now available for families affected by the heritable (genetic) form of retinoblastoma. This article explains more about the process, the benefits it can provide, and who is eligible....
In 2012, as part of our aim to reduce the delays in diagnosis of retinoblastoma (Rb) experienced by some families in the UK CHECT began to collect information from parents we called ‘Pathways to Diagnosis’. This information was gathered by support workers during the...
Dr Amy Gerrish tells us about the groundbreaking work her team is doing, co-funded by CHECT with Fight For Sight, to develop the genetic testing available for retinoblastoma. We want to say a huge thank you to the team and Dr Amy for their brilliant research. *Please...
Would you be prepared to offer your time for a clinical investigation currently recruiting at Moorfields Eye Hospital London? Provided you are aged 18 or over and meet the eligibility criteria, Professor Mandeep Sagoo’s team would be delighted to speak with you. 5+...
I am Dr Zhanhan Tu – an ophthalmologist, researcher and teacher based in the Ulverscroft Eye Unit at the University of Leicester. For the last ten years I have been working on normal and pathological eye development in infants and children, using optical...
